Cargando…
Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy
BACKGROUND: Near infrared (NIR) photoimmunotherapy (PIT) is a new type of cancer treatment based on a monoclonal antibody (mAb)-NIR phthalocyanine dye, (IR700) conjugate. In vitro cancer-specific cell death occurs during NIR light exposure in cells previously incubated with mAb-IR700 conjugates. How...
Autores principales: | Mitsunaga, Makoto, Nakajima, Takahito, Sano, Kohei, Kramer-Marek, Gabriela, Choyke, Peter L, Kobayashi, Hisataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502522/ https://www.ncbi.nlm.nih.gov/pubmed/22873679 http://dx.doi.org/10.1186/1471-2407-12-345 |
Ejemplares similares
-
Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules
por: Mitsunaga, Makoto, et al.
Publicado: (2011) -
Near-Infrared Photoimmunotherapy of Cancer
por: Kobayashi, Hisataka, et al.
Publicado: (2019) -
In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores
por: Sano, Kohei, et al.
Publicado: (2012) -
Comparative effectiveness of light emitting diodes (LEDs) and Lasers in near infrared photoimmunotherapy
por: Sato, Kazuhide, et al.
Publicado: (2016) -
Near infrared photoimmunotherapy for cancers: A translational perspective
por: Maruoka, Yasuhiro, et al.
Publicado: (2021)